|
|
|
Insider
Information: |
Baker Felix |
Relationship: |
Director, 10% Owner |
City: |
|
State: |
|
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
20 |
|
Direct
Shares |
927,207 |
|
Indirect Shares
|
141,861,898 |
|
|
Direct
Value |
$82,330,696 |
|
|
Indirect Value
|
$12,970,625,176 |
|
|
Total
Shares |
142,789,105 |
|
|
Total
Value |
$13,052,955,872 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
36
|
6
|
Stock
price went up :
|
15
|
6
|
Stock
price went down : |
21
|
0
|
|
|
|
Gain/Loss Ratio : |
0.0
|
6.0
|
Percentage
Gain/Loss : |
-24.3%
|
18.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Incyte Corp |
INCY |
Director, 10% Owner |
2023-09-29 |
559,963 |
2023-09-29 |
33,480,292 |
Premium* |
|
Ardea Biosciences Inc |
RDEA |
Director, 10% Owner |
2003-10-06 |
0 |
2012-02-01 |
116,454 |
Premium* |
|
Seagen Inc |
SGEN |
Director, 10% Owner |
2018-02-01 |
215,015 |
2018-02-01 |
44,355,335 |
Premium* |
|
Synageva BioPharma Corp |
GEVA |
Director, 10% Owner |
2015-06-22 |
100,503 |
2015-06-22 |
9,328,233 |
Premium* |
|
Viropharma Inc |
VPHM |
10% Owner |
2005-01-31 |
0 |
2011-12-14 |
303,264 |
Premium* |
|
Aceragen, Inc |
ACGN |
Director |
|
0 |
2017-07-03 |
145,453 |
Premium* |
|
Tapestry Pharmaceuticals Inc |
TPPHQ |
10% Owner |
|
0 |
2008-10-15 |
0 |
Premium* |
|
Genomic Health Inc |
GHDX |
Director, 10% Owner |
2012-10-01 |
288 |
2012-10-01 |
11,377,485 |
Premium* |
|
Allos Therapeutics Inc |
ALTH |
10% Owner |
|
0 |
2009-02-06 |
1,629 |
Premium* |
|
Biocryst Pharmaceuticals Inc |
BCRX |
10% Owner |
2016-08-16 |
46,918 |
2016-08-16 |
9,418,390 |
Premium* |
|
Heron Therapeutics Inc |
HRTX |
10% Owner |
|
0 |
2011-06-30 |
5,266,568 |
Premium* |
|
Adolor Corp |
ADLR |
10% Owner |
2010-04-26 |
0 |
2011-12-19 |
0 |
Premium* |
|
Diadexus Inc |
DDXS |
10% Owner |
|
0 |
2010-07-28 |
140,525 |
Premium* |
|
Pharmacyclics Inc |
PCYC |
10% Owner |
|
0 |
2011-08-22 |
1,809 |
Premium* |
|
Ocera Therapeutics Inc |
OCRX |
10% Owner |
2012-03-12 |
0 |
2012-03-14 |
57,704 |
Premium* |
|
XOMA Corporation |
XOMA |
Director, 10% Owner |
2012-10-29 |
0 |
2012-10-29 |
480,639 |
Premium* |
|
Neurogene |
NGNE |
10% Owner |
2015-08-07 |
4,520 |
|
0 |
Premium* |
|
Invitae Corp |
NVTA |
10% Owner |
|
0 |
2015-08-27 |
6,554,967 |
Premium* |
|
Bellicum Pharmaceuticals, Inc |
BLCM |
10% Owner |
|
0 |
2015-12-24 |
4,865,647 |
Premium* |
|
Kodiak Sciences Inc. |
KOD |
Director, 10% Owner |
2022-01-21 |
0 |
2022-06-06 |
15,967,504 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
1397 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 11 of 56
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
SGEN |
Seagen Inc |
Director |
|
2004-08-10 |
4 |
B |
$5.32 |
$65,400 |
I/I |
12,298 |
74,980 |
2.25 |
- |
|
VPHM |
Viropharma Inc |
10% Owner |
|
2008-10-21 |
4 |
A |
$2.74 |
$269 |
I/I |
98 |
75,075 |
0 |
- |
|
GHDX |
Genomic Health Inc |
Director |
|
2007-05-23 |
4 |
B |
$16.40 |
$36,264 |
I/I |
2,211 |
75,153 |
2.25 |
- |
|
SGEN |
Seagen Inc |
Director |
|
2005-04-29 |
4 |
B |
$3.99 |
$71,061 |
I/I |
17,766 |
75,439 |
2.25 |
- |
|
SGEN |
Seagen Inc |
Director |
|
2007-02-14 |
4/A |
S |
$8.76 |
$171,354 |
I/I |
(19,561) |
75,598 |
0 |
- |
|
SGEN |
Seagen Inc |
Director |
|
2007-02-14 |
4 |
S |
$8.72 |
$170,572 |
I/I |
(19,561) |
75,598 |
0 |
- |
|
SGEN |
Seagen Inc |
Director |
|
2006-06-26 |
4 |
B |
$4.00 |
$8,932 |
I/I |
2,232 |
76,660 |
2.17 |
- |
|
SGEN |
Seagen Inc |
Director |
|
2005-05-04 |
4 |
B |
$4.79 |
$6,935 |
I/I |
1,448 |
76,887 |
2.17 |
- |
|
GHDX |
Genomic Health Inc |
Director |
|
2007-05-24 |
4 |
B |
$16.31 |
$33,769 |
I/I |
2,066 |
77,219 |
2.25 |
- |
|
ALTH |
Allos Therapeutics Inc |
10% Owner |
|
2008-05-29 |
4 |
D |
$0.00 |
$0 |
I/I |
(4,610) |
77,376 |
0 |
- |
|
SGEN |
Seagen Inc |
Director |
|
2006-06-27 |
4 |
B |
$4.03 |
$8,509 |
I/I |
2,108 |
78,768 |
2.17 |
- |
|
ADLR |
Adolor Corp |
10% Owner |
|
2010-10-29 |
4 |
S |
$1.18 |
$445 |
I/I |
(376) |
79,054 |
0 |
- |
|
ADLR |
Adolor Corp |
10% Owner |
|
2010-10-28 |
4 |
S |
$1.19 |
$1,052 |
I/I |
(885) |
79,430 |
0 |
- |
|
ADLR |
Adolor Corp |
10% Owner |
|
2010-10-27 |
4 |
S |
$1.28 |
$1,037 |
I/I |
(802) |
80,315 |
0 |
- |
|
SGEN |
Seagen Inc |
Director |
|
2004-08-11 |
4 |
B |
$5.42 |
$29,416 |
I/I |
5,416 |
80,396 |
2.25 |
- |
|
GHDX |
Genomic Health Inc |
Director |
|
2007-05-25 |
4 |
B |
$16.24 |
$57,082 |
I/I |
3,514 |
80,733 |
2.25 |
- |
|
ADLR |
Adolor Corp |
10% Owner |
|
2010-04-23 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
81,117 |
|
- |
|
ALTH |
Allos Therapeutics Inc |
10% Owner |
|
2009-02-05 |
4 |
S |
$8.11 |
$37,828 |
I/I |
(4,646) |
81,423 |
0 |
- |
|
VPHM |
Viropharma Inc |
10% Owner |
|
2009-05-06 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
81,950 |
|
- |
|
ALTH |
Allos Therapeutics Inc |
10% Owner |
|
2008-05-28 |
4 |
D |
$0.00 |
$0 |
I/I |
(109,834) |
81,986 |
0 |
- |
|
VPHM |
Viropharma Inc |
10% Owner |
|
2009-05-07 |
4 |
B |
$5.72 |
$2,827 |
I/I |
494 |
82,444 |
1.42 |
- |
|
VPHM |
Viropharma Inc |
10% Owner |
|
2009-05-08 |
4 |
B |
$5.92 |
$1,765 |
I/I |
298 |
82,742 |
1.42 |
- |
|
VPHM |
Viropharma Inc |
10% Owner |
|
2009-05-11 |
4 |
B |
$5.86 |
$1,283 |
I/I |
219 |
82,961 |
1.42 |
- |
|
BCRX |
Biocryst Pharmaceuticals ... |
10% Owner |
|
2009-05-29 |
4 |
S |
$4.12 |
$38,305 |
I/I |
(9,226) |
83,188 |
0 |
- |
|
RDEA |
Ardea Biosciences Inc |
Director |
|
2010-04-06 |
4 |
B |
$20.00 |
$268,620 |
I/I |
13,431 |
83,467 |
2.25 |
- |
|
1397 Records found
|
|
Page 11 of 56 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|